MultivisionDx

Medtech & Digital Health · Helsinki

AI spatial biology for cancer diagnostics: computer vision analyses tumour biopsies → a patient-specific 'cancer fingerprint' predicting treatment response. Validated in 650 patients (Cell paper). Univ. of Helsinki spin-out; Arctic15 100 Innovations 3rd place 2026.

Pre-revenue📍 Helsinki📅 Founded 2025🎓 Univ. of Helsinki💶 €1M (pre-seed, Antler, 2025)

The row

Sector: Medtech & Digital Health
Stage: Pre-revenue — No sales yet
Location: Helsinki
Founded: 2025
Research origin: Univ. of Helsinki
Business ID: 3523619-5 · Finnish trade register
Funding: €1M (pre-seed, Antler, 2025)

Links

Website ↗

Where this sits on the map

MultivisionDx is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗

Row last checked 12 October 2026 Something wrong on this page? ↗